KALA - カラ・ファ―マシュ―ティカルズ （Kala Pharmaceuticals Inc.）

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. BridgeBio Pharma, Inc. (NASDAQ: BBIO ) shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia. Avalon GloboCare Corp. (NASDAQ: ALBT ) shares gained 53.5% to $3.3330. Azul S.A. (NYSE: AZUL ) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmaceuticals with a Buy and raised the price target from $12 to $20.Kala Pharmaceuticals recently said Q4 adjusted EPS results were higher year over year. TCR2 Therapeutics Inc. (NASDAQ: TCRR ) gained 28% to $1.55 after the company and Adaptimmune announced a strategic combination to create a preeminent cell therapy company for solid tumors.

Currently, Kala Pharmaceuticals Inc.’s (KALA) stock is trading at $21.50, marking a gain of 28.36% from last night’s close. At this price, the stock is -77.84% below its 52-week high of $97.00 and 506.59% above its 52-week low of $3.54. Based on the past 30-day period, the stock price is -3.27% below the high and […]

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze. Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard and some other stocks to watch that are moving up the list. Related Link: What Is A Short Squeeze? China Jo-Jo Drugstores (NASDAQ: CJJD ): The pharmaceutical retailer and distributor moves up two positions from last week’s leaderboard to top the week. Data shows 26.9% of the float short, compared to 10.7% last week. The cost to borrow is listed at 50.*%, up from last week’s 38.7%. The stock was also recently featured in Benzinga’s “Stock Whisper” Index thanks to increased interest in the name. Kala Pharmaceuticals (NASDAQ: KALA ): No stranger to the short squeeze leaderboard, Kala Pharmaceuticals moves up eight positions to rank second for the week.

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session. BridgeBio Pharma, Inc. (NASDAQ: BBIO ) shares surged 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia. Azul S.A. (NYSE: AZUL ) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) gained 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmaceuticals with a Buy and raised the price target from $12 to $20.Kala Pharmaceuticals recently said Q4 adjusted EPS … Full story available on Benzinga.com

NEW YORK , March 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBIO, KALA, AZUL, UNCY, and CIEN. … Full story available on Benzinga.com

In last trading session, Kala Pharmaceuticals Inc. (NASDAQ:KALA) saw 3.68 million shares changing hands with its beta currently measuring -0.55. Company’s recent per share price level of $36.67 trading at -$5.42 or -12.88% at ring of the bell on the day assigns it a market valuation of $36.30M. That closing price of KALA’s stock is … Kala Pharmaceuticals Inc. (NASDAQ:KALA) 90.35% Above Its 52-Week Low, How Long Will It Keep Rising? Read More »

ReShape Lifesciences (RSLS) +138%. Scilex (SCLX) +41%. Palisade Bio (PALI) -16%. Kala Pharmaceuticals (KALA) -15%.

Shares of Kala Pharmaceuticals Inc. have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company…

Current Technical and Performance analysis of the following stocks Kala Pharmaceuticals, Inc. (KALA) with the stream of 26.05% also noticed, India AT&T Inc. (T) showing a change of -0.14% in … The post Worth Watching Stocks: Kala Pharmaceuticals, Inc. (NASDAQ:KALA), AT&T Inc. (NYSE:T) appeared first on Stocks Equity .

Friday''s top analyst upgrades and downgrades included AMC Entertainment, CNH Industrial, Kala Pharmaceuticals, Opendoor Technologies, Tesla and TG Therapeutics.

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Alluring stocks: Genius Brands International, Inc. (NASDAQ:GNUS 0.32%), Kala Pharmaceuticals, Inc. (NASDAQ:KALA -3.09%) appeared first on Stocks Equity .

ARLINGTON, Mass., July 22, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to a new employee as an inducement award outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

Kala Pharmaceuticals Inc. (NASDAQ:KALA) traded at $0.38 at close of the session on Friday, 06/03/22, made an upward move of 4.89% on its previous day’s price. Looking at the stock we see that its previous close was $0.36 and the beta (5Y monthly) reads 0.62 with the day’s price range being $0.355 – $0.3951. In … Kala Pharmaceuticals Inc. (NASDAQ: KALA) Jumps 4.89%, Turning Investors Away Read More »

Wall Street analysts expect Kala Pharmaceuticals, Inc. to report earnings of per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have…

ARLINGTON, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies Healthcare Conference in New York, NY. Members from the management team are scheduled to participate in a fireside chat on Thursday, June 9, 2022 at 10:30 a.m. ET. Management will also be available for one-on-one meetings on Wednesday, June 8, 2022 and Thursday, June 9, 2022.